Literature DB >> 7702623

Regulation of the major histocompatibility complex class I mRNA expression by bile acids in cultured human hepatoma cells.

F Hirano1, H Tanaka, Y Makino, K Okamoto, M Inaba, T Miura, I Makino.   

Abstract

We investigated the effect of bile acids on major histocompatibility complex (MHC) class I gene expression in the cultured human hepatoma cell HepG2. Not only chenodeoxycholic acid, but its stereoisomer ursodeoxycholic acid as well, increased steady state level of MHC class I mRNA. When various bile acids were studied, inducibility of MHC class I mRNA was closely associated with the hydrophobicity of the corresponding bile acids. Pretreatment of the cells with a protein kinase C (PKC) inhibitor H7 suppressed induction of MHC class I mRNA by those bile acids. Furthermore, treatment of the cells with chenodeoxycholic acid significantly induced translocation of PKC from cytosol to membrane. In summary, our data strongly indicate up-regulatory effect of bile acids on MHC class I mRNA expression, most probably via activation of PKC-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7702623     DOI: 10.1006/bbrc.1995.1424

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Mechanism of bile salt-induced mucin secretion by cultured dog gallbladder epithelial cells.

Authors:  J H Klinkspoor; G N Tytgat; S P Lee; A K Groen
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

2.  Regulation of mdr2 P-glycoprotein expression by bile salts.

Authors:  C M Frijters; R Ottenhoff; M J van Wijland; C M van Nieuwkerk; A K Groen; R P Oude Elferink
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

3.  Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression.

Authors:  F Hirano; H Tanaka; Y Makino; K Okamoto; I Makino
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.